The purpose of the Novo Nordisk Foundation Sustain Programme is to encourage the scientific use of existing data, specifically for cardiometabolic disease (CMD) research, through a funding mechanism that supports both the custodians of the databases and the researchers who use the data. The goal is to sustain high-quality health databases, encourage custodians to make data accessible, and ultimately advance understanding, prevention, and treatment of CMD.